You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 4, 2025

Drug Price Trends for CARTIA XT


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for CARTIA XT

Average Pharmacy Cost for CARTIA XT

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug NameNDCPrice/Unit ($)UnitDate
CARTIA XT 180 MG CAPSULE 62037-0598-90 0.19378 EACH 2025-03-19
CARTIA XT 240 MG CAPSULE 62037-0599-05 0.22221 EACH 2025-03-19
CARTIA XT 180 MG CAPSULE 62037-0598-05 0.19378 EACH 2025-03-19
CARTIA XT 240 MG CAPSULE 62037-0599-90 0.22221 EACH 2025-03-19
CARTIA XT 120 MG CAPSULE 62037-0597-05 0.15214 EACH 2025-03-19
CARTIA XT 300 MG CAPSULE 62037-0600-90 0.31781 EACH 2025-03-19
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 6 of 6 entries

Market Analysis and Price Projections for Cartia XT

Introduction

Cartia XT, a calcium channel blocker, is used to treat hypertension and manage chronic stable angina and angina due to coronary artery spasm. Here, we will delve into the market analysis and price projections for this medication.

Market Overview

Cartia XT, the generic version of Cardizem CD, is a significant player in the cardiovascular drug market. The drug's market presence is influenced by several factors, including competition from other generics, regulatory environments, and patient demand.

Generic Competition

The entry of generic versions of cardiovascular drugs has significantly impacted the market. Generic drugs approved in recent years have yielded substantial cost savings, with estimates suggesting $18.9 billion in total savings during the 12 months following their approvals in 2022[3].

Regulatory Environment

Historically, the market for Cartia XT has been affected by antitrust lawsuits. For instance, an $80 million settlement was reached due to allegations that Aventis Pharmaceuticals Inc. and Andrx Corporation conspired to keep the generic version of Cardizem CD off the market, thereby maintaining higher prices for the brand-name drug[4].

Pricing and Cost Analysis

The pricing of Cartia XT varies based on dosage and quantity.

Current Pricing

  • The cost for Cartia XT oral capsules, extended release, ranges from approximately $35.55 for 90 capsules of the 120 mg/24 hours dosage to $86.04 for 90 capsules of the 300 mg/24 hours dosage[2].
Dosage Quantity Price per Unit Total Price
120 mg/24 hours 90 $0.40 $35.55
180 mg/24 hours 90 $0.57 $51.13
240 mg/24 hours 90 $0.58 $52.47
300 mg/24 hours 90 $0.96 $86.04

Discounts and Patient Assistance Programs

Patients can benefit from various discounts and patient assistance programs. For example, the Drugs.com Discount Card can save patients up to 80% on prescription medicines. Additionally, programs like Rx Outreach offer discounted prices for eligible patients, with some medications available for a fee of $20 for up to a 180-day supply[2].

Price Projections

Impact of Generic Competition

The presence of generic competition is expected to continue driving down prices. As seen with other generic drug approvals, the entry of new generics can lead to significant price reductions. For instance, the average price of lurasidone hydrochloride tablets fell from about $47 to less than $2 per tablet after generic versions were approved[3].

Medicare and Insurance Coverage

Medicare Part D plans have been effective in providing substantial discounts on drug prices. Part D prices for drugs like Cartia XT have increased more slowly than average wholesale prices (AWPs), translating into reliable out-of-pocket savings for beneficiaries[5].

Market Trends and Future Outlook

Increasing Demand for Cardiovascular Medications

The demand for cardiovascular medications is expected to rise due to an aging population and increasing prevalence of cardiovascular diseases. This demand will likely sustain the market for Cartia XT and other similar medications.

Regulatory and Legal Factors

Future price projections will be influenced by regulatory actions and legal outcomes. Any changes in antitrust laws or enforcement could impact how generic drugs are marketed and priced.

Key Takeaways

  • Generic Competition: The presence of generic versions significantly reduces the price of Cartia XT.
  • Discounts and Assistance Programs: Various programs offer substantial savings for patients.
  • Regulatory Environment: Antitrust lawsuits and regulatory actions can impact market dynamics.
  • Demand and Market Trends: Increasing demand for cardiovascular medications will sustain the market.

FAQs

  1. What is Cartia XT used for? Cartia XT is used for the treatment of hypertension and the management of chronic stable angina and angina due to coronary artery spasm[1].

  2. How much does Cartia XT cost? The cost of Cartia XT varies by dosage and quantity, ranging from approximately $35.55 for 90 capsules of the 120 mg/24 hours dosage to $86.04 for 90 capsules of the 300 mg/24 hours dosage[2].

  3. Are there any discounts available for Cartia XT? Yes, discounts are available through programs like the Drugs.com Discount Card and patient assistance programs such as Rx Outreach[2].

  4. How does Medicare Part D affect the pricing of Cartia XT? Medicare Part D plans provide substantial discounts on drug prices, with Part D prices increasing more slowly than average wholesale prices (AWPs)[5].

  5. What impact does generic competition have on the price of Cartia XT? Generic competition significantly reduces the price of Cartia XT, as seen with other generic drug approvals that have led to substantial cost savings[3].

Sources

  1. Drugs.com: Cartia XT: Package Insert / Prescribing Information.
  2. Drugs.com: Cartia XT Prices, Coupons, Copay Cards & Patient Assistance.
  3. FDA: Estimating Cost Savings from New Generic Drug Approvals in 2022.
  4. California Department of Justice: Attorney General Lockyer Announces $80 Million Settlement of Antitrust Case Against Drug Makers.
  5. CMS: Medicare Prescription Drug Coverage: Part D Savings Analysis and Tables.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.